The Role of Electrophysiology Testing in Survivors of Unexplained Cardiac Arrest
Sudden Cardiac DeathSudden cardiac death (SCD) remains a major cause of mortality within developed nations despite aggressive efforts to reduce its societal burden. Despite extensive clinical and genetic investigations, a subgroup of cardiac arrests remain unexplained, highlighting the potential contribution of additional cardiac conditions that may not be identified with contemporary diagnostic algorithms. The EPS ARREST study aims to evaluate the role of invasive electrophysiology study within this patient population.
null
Participation Requirements
-
Sex:
ALL -
Eligible Ages:
0 and up
Participation Criteria
Inclusion Criteria:
1. Unexplained cardiac arrest requiring cardioversion or defibrillation
2. Willing and able to sign informed consent
Exclusion Criteria:
1. Coronary artery disease (stenosis \> 50%) and clinical findings consistent with an ischemic arrest
2. Reduced left ventricular function (left ventricular ejection fraction \< 50%) on echocardiogram or cardiac MRI.
3. Persistent resting QTc \> 460 msec for males and 480 msec for females
4. Resting QTc \< 350 msec
5. Type I Brugada ECG with \>/= 2 mm ST elevation in V1 and/or V2 (Spontaneous or Drug-Induced)
6. Polymorphic or bidirectional ventricular tachycardia observed with exertion on exercise treadmill testing
7. Clinical, electrocardiographic, and/or imaging findings consistent with a diagnosis of arrhythmogenic right ventricular cardiomyopathy
8. Myocarditis
9. Reversible cause of cardiac arrest such as marked hypokalemia (\<2.8 mmol/l) or drug overdose sufficient in severity without other cause to explain the cardiac arrest.
10. Arrhythmic mitral valve prolapse syndrome
11. Documented ventricular fibrillation initiated by a short-coupled premature ventricular contraction
Study Location
University of British Columbia
University of British ColumbiaVancouver, British Columbia
Canada
Contact Study Team
Andrew D Krahn, MD
Zachary Laksman, MD
Toronto General Hospital
Toronto General HospitalToronto, Ontario
Canada
Contact Study Team
Michael H Gollob, MD
British Columbia Children's Hospital
British Columbia Children's HospitalVancouver, British Columbia
Canada
Contact Study Team
Shubhayan Sanatani, MD
London Health Sciences Centre
London Health Sciences CentreLondon, Ontario
Canada
Contact Study Team
Jason D Roberts, MD MAS
QEII Health Sciences Centre
QEII Health Sciences CentreHalifax, Nova Scotia
Canada
Contact Study Team
Ciorsti MacIntyre, MD
Martin Gardner, MD
Montreal Heart Institute
Montreal Heart InstituteMontreal, Quebec
Canada
Contact Study Team
Rafik Tadros, MD PhD
University of Calgary
University of CalgaryCalgary, Alberta
Canada
Contact Study Team
George Veenhuyzen, MD
Stephen Wilton, MD
Hamilton Health Sciences
Hamilton Health SciencesHamilton, Ontario
Canada
Contact Study Team
Jeff Healey, MD
Laval University
Laval UniversityQuebec City, Quebec
Canada
Contact Study Team
Christian Steinberg, MD
- Study Sponsored By
- Western University, Canada
- Participants Required
- More Information
- Study ID:
NCT03079414